lifestyle.massnews.com

Author: SEED Therapeutics

SEED Therapeutics Reports Tumor Eradication in a Neuroblastoma In Vivo Model with Clinical-Stage RBM39 Molecular Glue Degrader ST-01156

April 22, 2026
SEED Therapeutics Announces Poster Presentation at AACR Annual Meeting 2026

March 30, 2026